Patents by Inventor Nicolas Wolff
Nicolas Wolff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200365932Abstract: A battery module comprises at least one battery cell and a cell mount, whereby the battery cell has a cylindrical cell housing with an external lateral surface, whereby an external thread is created in the lateral surface, and whereby the cell mount has at least one threaded hole with an internal thread into which the at least one battery cell is screwed in or can be screwed in.Type: ApplicationFiled: May 18, 2020Publication date: November 19, 2020Applicant: VOLKSWAGEN AKTIENGESELLSCHAFTInventors: Bastian SCHAAR, Nicolas WOLFF
-
Patent number: 10227653Abstract: The invention relates to polypeptides containing a cytoplasmic domain ending with a MAST-2 binding domain, from 11 to 13 residues, the first two residues of which are S and W, and the last four residues of which are Q, T, R and L, the polypeptides presenting a high affinity for the PDZ domain of the human MAST2 protein. The invention also relates to polynucleotides, vectors, lentiviral particles, cells as well as compositions containing the same. The invention is also directed to the use of the polypeptides, polynucleotides, vectors, lentiviral particles, cells and compositions in the treatment and/or prevention of a disease, disorder or condition, which alters the Central Nervous System (CNS) and/or the Peripheral Nervous System (PNS). The invention also concerns molecular signatures of cellular genes to determine the neurosurvival and/or neuroprotection activity of a molecule.Type: GrantFiled: September 14, 2016Date of Patent: March 12, 2019Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)Inventors: Christophe Prehaud, Monique Lafon, Nicolas Wolff, Zakir Khan, Elouan Terrien, Sandrine Vitry
-
Publication number: 20170022567Abstract: The invention relates to polypeptides containing a cytoplasmic domain ending with a MAST-2 binding domain, from 11 to 13 residues, the first two residues of which are S and W, and the last four residues of which are Q, T, R and L, the polypeptides presenting a high affinity for the PDZ domain of the human MAST2 protein. The invention also relates to polynucleotides, vectors, lentiviral particles, cells as well as compositions containing the same. The invention is also directed to the use of the polypeptides, polynucleotides, vectors, lentiviral particles, cells and compositions in the treatment and/or prevention of a disease, disorder or condition, which alters the Central Nervous System (CNS) and/or the Peripheral Nervous System (PNS). The invention also concerns molecular signatures of cellular genes to determine the neurosurvival and/or neuroprotection activity of a molecule.Type: ApplicationFiled: September 14, 2016Publication date: January 26, 2017Inventors: Christophe Prehaud, Monique Lafon, Nicolas Wolff, Zakir Khan, Elouan Terrien, Sandrine Vitry
-
Patent number: 9475851Abstract: The invention relates to polypeptides containing a cytoplasmic domain ending with a MAST-2 binding domain, from 11 to 13 residues, the first two residues of which are S and W, and the last four residues of which are Q, T, R and L, the polypeptides presenting a high affinity for the PDZ domain of the human MAST2 protein. The invention also relates to polynucleotides, vectors, lentiviral particles, cells as well as compositions containing the same. The invention is also directed to the use of the polypeptides, polynucleotides, vectors, lentiviral particles, cells and compositions in the treatment and/or prevention of a disease, disorder or condition, which alters the Central Nervous System (CNS) and/or the Peripheral Nervous System (PNS). The invention also concerns molecular signatures of cellular genes to determine the neurosurvival and/or neuroprotection activity of a molecule.Type: GrantFiled: November 7, 2012Date of Patent: October 25, 2016Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIEInventors: Christophe Prehaud, Monique Lafon, Nicolas Wolff, Zakir Khan, Elouan Terrien, Sandrine Vitry
-
Patent number: 9234005Abstract: The application provides products, which may trigger pro-apoptotic or pro-death effects on neoplastic cells and/or tissues of the human nervous system, more particularly on neoplastic cells and/or tissues of the human CNS. The products of the application can be used as anti-proliferative or tumoricid agents in the treatment and/or palliation and/or prevention of neoplasms of the human nervous system, more particularly of glioblastoma or brain stem glioma. Therefore, the application also relates to compositions, such as pharmaceutical compositions or drugs, which comprise at least one of said products, as well as to the biotechnological and medical applications of said products and compositions.Type: GrantFiled: October 11, 2012Date of Patent: January 12, 2016Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE PARISInventors: Nicolas Wolff, Monique Lafon, Nicolas Babault
-
Publication number: 20140315822Abstract: The invention relates to polypeptides containing a cytoplasmic domain ending with a MAST-2 binding domain, from 11 to 13 residues, the first two residues of which are S and W, and the last four residues of which are Q, T, R and L, said polypeptides presenting a high affinity for the PDZ domain of the human MAST2 protein. The invention also relates to polynucleotides, vectors, lentiviral particles, cells as well as compositions comprising the same. The invention is also directed to the use of said polypeptides, polynucleotides, vectors, lentiviral particles, cells and compositions in the treatment and/or prevention of a disease, disorder or condition, which alters the Central Nervous System (CNS) and/or the Peripheral Nervous System (PNS). The invention also concerns molecular signatures of cellular genes to determine the neurosurvival and/or neuroprotection activity of a molecule.Type: ApplicationFiled: November 7, 2012Publication date: October 23, 2014Applicant: CENTRE NATIONAL DE LA RECHERCE SCIENTIFIQUEInventors: Christophe Prehaud, Monique Lafon, Nicolas Wolff, Zakir Khan, Elouan Terrien, Sandrine Vitry
-
Publication number: 20100227526Abstract: A system for animating decorative elements or products moved by means of strings connecting the decorative elements to an animating mechanism includes a closed animating device (2) in which the animating mechanism is arranged and enclosed, decorative elements or products (4) animated by animating strings (5), the decorative elements (4) and their animating strings (5) being arranged outside the animating device (2) and distributed in a space to be decorated, control wires (6) being provided to connect the animating strings (5) of the decorative elements (4) to the animating mechanism, and elements (7) for transmitting movements to the decorative elements (4). The transmitting elements are distributed in the space to be decorated depending on the location of the decorative elements (4) relative to the animating device (2).Type: ApplicationFiled: January 22, 2007Publication date: September 9, 2010Applicant: Adjl"Atelier Des Jum"sInventors: Nicolas Wolff, Bastien Wolff
-
Publication number: 20090181614Abstract: The present invention comprises a computer-implemented method for providing audio content to mobile devices via a simple, efficient telephony-based system that delivers on-demand playback to a mobile device. The present invention dynamically allocates separate and unique direct inward dialing (DID) numbers to unique combinations of identifiable user-specific mobile devices and specific pieces of audio content such that a user receives a uniquely allocated DID number at the mobile device that links to a specific piece of stored audio content. Calling a DID number enables playback of the associated specific piece of stored audio content to an identifiable user-specific mobile device. A user may call the DID number conveniently at any time and hear playback of the stored audio content without having to first select from a series menu to identify and initiate playback of the piece of stored audio content.Type: ApplicationFiled: January 15, 2008Publication date: July 16, 2009Inventors: Nicolas Wolff, Erik Schwartz